Healthcare -
Biotechnology - NASDAQ - US
$ 4.62
0.217 %
$ 284 M
Market Cap
38.5
P/E
GLUE - OPERATING INCOME
Operating Income GLUE - Monte Rosa Therapeutics, Inc.
-81.1 M
LAST VALUE
15.04%
2 YEAR CAGR
-58.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR